Erratum: Control of allergen-induced inflammation and hyperresponsiveness by the metalloproteinase ADAMTS-12 (Journal Immunol. (2012) 189:9 (4135-4143) DOI: 10.4049/jimmunol.1103739);Control of allergen-induced inflammation and hyperresponsiveness by the metalloproteinase ADAMTS-12

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4135-4143

  Paulissen, Geneviève ^a   El Hour, Mehdi ^a   Rocks, Natacha ^a   Guéders, Maud M ^a   Bureau, Fabrice ^b   Foidart, Jean Michel ^a   Lopez Otin, Carlos ^c   Noel, Agnès ^a   Cataldo, Didier D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS12 PROTEIN; EOTAXIN; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; MESSENGER RNA; METALLOPROTEINASE; METHACHOLINE; OVALBUMIN; RANTES; ST2 RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHITIS; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL COUNT; CONTROLLED STUDY; EOSINOPHIL COUNT; EOSINOPHILIA; GENE EXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MALE; MAST CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

EID: 84867309055     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2100809     Document Type: Erratum

References (61)

1. Masoli, M., D. Fabian, S. Holt, and R. Beasley; Global Initiative for Asthma (GINA) Program. 2004. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478.
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barnéon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323: 1033-1039.
3. Louis, R., L. C. Lau, A. O. Bron, A. C. Roldaan, M. Radermecker, and R. Djukanović. 2000. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 161: 9-16.
4. Louis, R., J. Sele, M. Henket, D. Cataldo, J. Bettiol, L. Seiden, and P. Bartsch. 2002. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 57: 907-912.
5. Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745.
6. Chung, K. F., and P. J. Barnes. 1999. Cytokines in asthma. Thorax 54: 825-857.
7. Lukacs, N. W. 2001. Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 1: 108-116.
8. O'Byrne, P. M., M. D. Inman, and E. Adelroth. 2004. Reassessing the Th2 cytokine basis of asthma. Trends Pharmacol. Sci. 25: 244-248.
9. Cataldo, D. D., K. G. Tournoy, K. Vermaelen, C. Munaut, J. M. Foidart, R. Louis, A. Noël, and R. A. Pauwels. 2002. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am. J. Pathol. 161: 491-498.
10. Gueders, M. M., S. J. Hirst, F. Quesada-Calvo, G. Paulissen, J. Hacha, C. Gilles, P. Gosset, R. Louis, J. M. Foidart, C. Lopez-Otin, et al. 2010. MMP-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 43: 286-295.
11. Corry, D. B., K. Rishi, J. Kanellis, A. Kiss, L. Z. Song Lz, J. Xu, L. Feng, Z. Werb, and F. Kheradmand. 2002. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol. 3: 347-353.
12. Gueders, M. M., M. Balbin, N. Rocks, J. M. Foidart, P. Gosset, R. Louis, S. Shapiro, C. Lopez-Otin, A. Noël, and D. D. Cataldo. 2005. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J. Immunol. 175: 2589-2597.
13. McMillan, S. J., J. Kearley, J. D. Campbell, X. W. Zhu, K. Y. Larbi, J. M. Shipley, R. M. Senior, S. Nourshargh, and C. M. Lloyd. 2004. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J. Immunol. 172: 2586-2594.
14. Mehra, D., D. I. Sternberg, Y. Jia, S. Canfield, V. Lemaitre, T. Nkyimbeng, J.Wilder, J. Sonett, and J. D'Armiento. 2010. Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L189-L196.
15. Paulissen, G., N. Rocks, M. M. Guéders, D. Bedoret, C. Crahay, F. Quesada-Calvo, J. Hacha, S. Bekaert, C. Desmet, J. M. Foidart, et al. 2011. ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation. Eur. J. Immunol. 41: 380-391.
16. Van Eerdewegh, P., R. D. Little, J. Dupuis, R. G. Del Mastro, K. Falls, J. Simon, D. Torrey, S. Pandit, J. McKenny, K. Braunschweiger, et al. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418: 426-430.
17. Mathews, J. A., J. Ford, S. Norton, D. Kang, A. Dellinger, D. R. Gibb, A. Q. Ford, H. Massay, C. L. Kepley, P. Scherle, et al. 2011. A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy 66: 1193-1200.
18. Seals, D. F., and S. A. Courtneidge. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17: 7-30.
19. Foley, S. C., A. K. Mogas, R. Olivenstein, P. O. Fiset, J. Chakir, J. Bourbeau, P. Ernst, C. Lemière, J. G. Martin, and Q. Hamid. 2007. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J. Allergy Clin. Immunol. 119: 863-871.
20. Paulissen, G., N. Rocks, F. Quesada-Calvo, P. Gosset, J. M. Foidart, A. Noel, R. Louis, and D. D. Cataldo. 2006. Expression of ADAMs and their inhibitors in sputum from patients with asthma. Mol. Med. 12: 171-179.
21. King, N. E., N. Zimmermann, S. M. Pope, P. C. Fulkerson, N. M. Nikolaidis, A. Mishra, D. P. Witte, and M. E. Rothenberg. 2004. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am. J. Respir. Cell Mol. Biol. 31: 257-265.
22. Naus, S., M. R. Blanchet, K. Gossens, C. Zaph, J. W. Bartsch, K. M. McNagny, and H. J. Ziltener. 2010. The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am. J. Respir. Crit. Care Med. 181: 1318-1328.
23. Kurz, T., S. Hoffjan, M. G. Hayes, D. Schneider, R. Nicolae, A. Heinzmann, S. P. Jerkic, R. Parry, N. J. Cox, K. A. Deichmann, and C. Ober. 2006. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J. Allergy Clin. Immunol. 118: 396-402.
24. Apte, S. S. 2009. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J. Biol. Chem. 284: 31493-31497.
25. Colige, A., F. Ruggiero, I. Vandenberghe, J. Dubail, F. Kesteloot, J. Van Beeumen, A. Beschin, L. Brys, C. M. Lapière, and B. Nusgens. 2005. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J. Biol. Chem. 280: 34397-34408.
26. Cal, S., J. M. Arguelles, P. L. Fernandez, and C. López- Otín. 2001. Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J. Biol. Chem. 276: 17932-17940.
27. Rocks, N., G. Paulissen, F. Quesada Calvo, M. Polette, M. Gueders, C. Munaut, J. M. Foidart, A. Noël, P. Birembaut, and D. Cataldo. 2006. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br. J. Cancer 94: 724-730.
28. El Hour, M., A. Moncada-Pazos, S. Blacher, A. Masset, S. Cal, S. Berndt, J. Detilleux, L. Host, A. J. Obaya, C. Maillard, et al. 2010. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene 29: 3025-3032.
29. Hammad, H., M. Chieppa, F. Perros, M. A. Willart, R. N. Germain, and B. N. Lambrecht. 2009. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15: 410-416.
30. Hantos, Z., B. Daróczy, B. Suki, S. Nagy, and J. J. Fredberg. 1992. Input impedance and peripheral inhomogeneity of dog lungs. J. Appl. Physiol. 72: 168-178.
31. Phipps, S., C. E. Lam, G. E. Kaiko, S. Y. Foo, A. Collison, J. Mattes, J. Barry, S. Davidson, K. Oreo, L. Smith, et al. 2009. Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th2 responses. Am. J. Respir. Crit. Care Med. 179: 883-893.
32. Gueders, M. M., G. Paulissen, C. Crahay, F. Quesada-Calvo, J. Hacha, C. Van Hove, K. Tournoy, R. Louis, J. M. Foidart, A. Noël, and D. D. Cataldo. 2009. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm. Res. 58: 845-854.
33. Van Hove, C. L., T. Maes, D. D. Cataldo, M. M. Guéders, E. Palmans, G. F. Joos, and K. G. Tournoy. 2009. Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice. Int. Arch. Allergy Immunol. 149: 195-207.
34. Corry, D. B., A. Kiss, L. Z. Song, L. Song, J. Xu, S. H. Lee, Z. Werb, and F. Kheradmand. 2004. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J. 18: 995-997.
35. Stirling, R. G., E. L. van Rensen, P. J. Barnes, and K. F. Chung. 2001. Interleukin-5 induces CD34+ eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am. J. Respir. Crit. Care Med. 164: 1403-1409.
36. Rojas-Ramos, E., A. F. Avalos, L. Pérez-Fernandez, F. Cuevas-Schacht, E. Valencia-Maqueda, and L. M. Terán. 2003. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. Eur. Respir. J. 22: 310-316.
37. Fulkerson, P. C., N. Zimmermann, L. M. Hassman, F. D. Finkelman, and M. E. Rothenberg. 2004. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-γ. J. Immunol. 173: 7565-7574.
38. Cherry, W. B., J. Yoon, K. R. Bartemes, K. Iijima, and H. Kita. 2008. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121: 1484-1490.
39. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
40. Hsu, C. L., C. V. Neilsen, and P. J. Bryce. 2010. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 5: e11944.
41. Lloyd, C. M. 2010. IL-33 family members and asthma: bridging innate and adaptive immune responses. Curr. Opin. Immunol. 22: 800-806.
42. Yagami, A., K. Orihara, H. Morita, K. Futamura, N. Hashimoto, K. Matsumoto, H. Saito, and A. Matsuda. 2010. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 185: 5743-5750.
43. Cox, J. H., A. E. Starr, R. Kappelhoff, R. Yan, C. R. Roberts, and C. M. Overall. 2010. Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. Arthritis Rheum. 62: 3645-3655.
44. Van Den Steen, P. E., A. Wuyts, S. J. Husson, P. Proost, J. Van Damme, and G. Opdenakker. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270: 3739-3749.
45. Tester, A. M., J. H. Cox, A. R. Connor, A. E. Starr, R. A. Dean, X. S. Puente, C. López-Otín, and C. M. Overall. 2007. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2: e312.
46. Overall, C. M., and O. Kleifeld. 2006. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6: 227-239.
47. Overall, C. M., and O. Kleifeld. 2006. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br. J. Cancer 94: 941-946.
48. Liu, C. J., W. Kong, K. Xu, Y. Luan, K. Ilalov, B. Sehgal, S. Yu, R. D. Howell, and P. E. Di Cesare. 2006. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J. Biol. Chem. 281: 15800-15808.
49. Llamazares, M., A. J. Obaya, A. Moncada-Pazos, R. Heljasvaara, J. Espada, C. López-Otín, and S. Cal. 2007. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J. Cell Sci. 120: 3544-3552.
50. Luque, A., D. R. Carpizo, and M. L. Iruela-Arispe. 2003. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J. Biol. Chem. 278: 23656-23665.
51. Mirochnik, Y., A. Kwiatek, and O. V. Volpert. 2008. Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. Curr. Drug Targets 9: 851-862.
52. Van den Steen, P. E., P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker. 2000. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681.
53. McQuibban, G. A., J. H. Gong, E. M. Tam, C. A. McCulloch, I. Clark-Lewis, and C. M. Overall. 2000. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202-1206.
54. Cauwe, B., P. E. Van den Steen, and G. Opdenakker. 2007. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42: 113-185.
55. Noguchi, E., Y. Ohtsuki, K. Tokunaga, M. Yamaoka-Sageshima, K. Ichikawa, T. Aoki, M. Shibasaki, and T. Arinami. 2006. ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin. Exp. Allergy 36: 602-608.
56. Werner, M., N. Herbon, H. Gohlke, J. Altmüller, M. Knapp, J. Heinrich, and M. Wjst. 2004. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin. Exp. Allergy 34: 26-31.
57. Hirota, T., K. Hasegawa, K. Obara, A. Matsuda, M. Akahoshi, K. Nakashima, T. Shirakawa, S. Doi, K. Fujita, Y. Suzuki, et al. 2006. Association between ADAM33 polymorphisms and adult asthma in the Japanese population. Clin. Exp. Allergy 36: 884-891.
58. Howard, T. D., D. S. Postma, H. Jongepier, W. C. Moore, G. H. Koppelman, S. L. Zheng, J. Xu, E. R. Bleecker, and D. A. Meyers. 2003. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112: 717-722.
59. Wang, P., Q. J. Liu, J. S. Li, H. C. Li, C. H. Wei, C. H. Guo, and Y. Q. Gong. 2006. Lack of association between ADAM33 gene and asthma in a Chinese population. Int. J. Immunogenet. 33: 303-306.
60. Lind, D. L., S. Choudhry, N. Ung, E. Ziv, P. C. Avila, K. Salari, C. Ha, E. G. Lovins, N. E. Coyle, S. Nazario, et al. 2003. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 168: 1312-1316.
61. Chen, C., X. Huang, and D. Sheppard. 2006. ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol. Cell. Biol. 26: 6950-6956.